ExchangeDEX+

Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Commodity Zero-Fee Gala

United Therapeutics Corp. (UTHR)

NASDAQ

$476.05

$+0.14

(+0.03%)

United Therapeutics Corp. (UTHR) Live Price Chart

Page last updated: 2026-02-12 20:59:55

Key Market Data

Market Cap	$20.50B
Open	$475.45
High	$519.99
Low	$18.22
Previous Close	$475.85
Price Change	$+0.14
Percentage Change	+0.03%
Volume	215K

United Therapeutics Corp. (UTHR) Stock Price Today

United Therapeutics Corp. (UTHR) is currently trading at $476.05 as of 2026-02-12 20:59:55, reflecting a +0.03% move ($+0.14) from the previous close.

In the short term, the stock has returned +6.62% over the past four weeks. Over the last 12 months, United Therapeutics Corp. has recorded a +28.40% price change, indicating a strong performance relative to the broader market.

United Therapeutics Corp. (UTHR) 7-Day Stock Price Changes

Over the past seven days, United Therapeutics Corp. has traded within a short-term range shaped by market sentiment in the PHARMACEUTICAL PREPARATIONS sector. During this period, the stock moved from its previous closing price of $483.81 to the latest recorded price of $476.05, reflecting an intraday change of +0.03%. Daily movements highlight shifts in trading volume (214,793), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, UTHR has delivered a +6.62% return over the past month and a +28.40% change in the last 12 months, indicating a strong trend relative to its broader sector peers.

How to Buy United Therapeutics Corp. (UTHR)

You can buy and trade UTHR on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for UTHR and Execute Your Trade

Open the trading page, enter UTHR in the search bar, select the amount of UTHR you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is United Therapeutics Corp. (UTHR)?

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

United Therapeutics Corp. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	1,305
Sector	PHARMACEUTICAL PREPARATIONS
Company Website	https://www.unither.com

Frequently Asked Questions (FAQ)

1.What is the current share price of United Therapeutics Corp.?

The latest trading price for United Therapeutics Corp. (Common Stock) is $ 476.05, compared with a previous closing price of $ 475.85. That means the stock has moved +0.03% so far today. Intraday price updates and recent trading activity for UTHR can be tracked on the live chart and quote section on this page.

2.Is United Therapeutics Corp. stock going up or down?

Looking at recent performances, UTHR has returned +6.62% over the past month, +51.56% over the last six months and +28.40% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe strong price momentum for United Therapeutics Corp. stock, but keep in mind that past returns do not guarantee future results.

3.Where does UTHR currently sit relative to its 52-week high and low?

In the most recent 52-week period, United Therapeutics Corp. has traded between a low of $ 266.98 and a high of $ 519.99. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether UTHR is currently nearer the top or the bottom of its one-year trading band.

4.How is United Therapeutics Corp. classified by sector and industry?

United Therapeutics Corp. is classified in the PHARMACEUTICAL PREPARATIONS sector. In practice, this means United Therapeutics Corp. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing UTHR’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the PHARMACEUTICAL PREPARATIONS sector could influence United Therapeutics Corp.’s performance.

5.Where is United Therapeutics Corp. listed and how large is it by market value?

United Therapeutics Corp. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 20.50B, the company is classified as a Large-cap stock. Market cap gives a quick sense of United Therapeutics Corp.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does UTHR's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ 29.54 summarises how much profit United Therapeutics Corp. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track United Therapeutics Corp.'s financial performance over time?

To follow United Therapeutics Corp.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how UTHR is performing and how the market is responding.

8.When is United Therapeutics Corp. expected to report earnings?

United Therapeutics Corp.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for UTHR, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in United Therapeutics Corp.'s earnings reports?

United Therapeutics Corp.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether UTHR is meeting, beating or missing expectations.

10.How can I stay informed about United Therapeutics Corp.'s results and guidance?

You can stay up to date on United Therapeutics Corp. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for UTHR on this page helps you see how new information is being reflected in the stock.

11.Does United Therapeutics Corp. pay a regular cash dividend to its shareholders?

United Therapeutics Corp. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor UTHR's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for UTHR?

Based on the latest earnings data, UTHR has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether United Therapeutics Corp. is an attractive income stock. The dividend payout ratio measures what percentage of earnings United Therapeutics Corp. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is United Therapeutics Corp.?

United Therapeutics Corp. is a publicly traded company in the PHARMACEUTICAL PREPARATIONS industry within the PHARMACEUTICAL PREPARATIONS sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is UTHR valued in terms of P/E ratio and EPS?

United Therapeutics Corp. currently trades at a price-to-earnings (P/E) ratio of 16.11, based on trailing-twelve-month earnings per share (EPS) of $ 29.54. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of United Therapeutics Corp.'s earnings. Comparing UTHR's P/E and EPS to those of other PHARMACEUTICAL PREPARATIONS companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as United Therapeutics Corp.

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Franklin Resources, Inc.

BEN

ChargePoint Holdings, Inc.

CHPT

Entergy Corporation

ETR

Goldman Sachs Group Inc.

Millrose Properties, Inc.

MRP

Top Gainers

Browse today's leading gainers in the US stock market

Haoxin Holdings Limited

HXHX

IPG Photonics Corporation

IPGP

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

UTHR-to-USD Calculator

Amount

UTHR

USD

1 UTHR = 476.045 USD